Patents
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
07/2004
07/15/2004WO2004058959A1 PROCESS FOR PRODUCING PNPase
07/15/2004WO2004058940A2 Sirna-mediated gene silencing
07/15/2004WO2004058814A1 Enzymes and polynucleotides encoding the same
07/15/2004WO2004058794A1 Methods and compositions for the tandem synthesis of two or more oligonuleotides on the same solid support
07/15/2004WO2004058793A1 Nucleotide derivatives and dna microarray
07/15/2004WO2004058779A1 Process for preparing phosphorodiamidites
07/15/2004WO2004058392A2 Intramolecular triplet-sensitized o-nitrophenylethyl photoprotective groups
07/15/2004WO2004058391A2 Photoactivatable two-stage protective groups for the synthesis of biopolymers
07/15/2004WO2004058300A1 Sequences diagnostic for foot and mouth disease
07/15/2004WO2004058179A2 Immunostimulatory sequence oligonucleotides and methods of using the same
07/15/2004WO2004058166A2 Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection
07/15/2004WO2004058159A2 Branched immunomodulatory compounds and methods of using the same
07/15/2004WO2004058147A2 Human chondroitinase glycoprotein (chasegp), process for preparing the same, and pharmaceutical compositions comprising thereof
07/15/2004WO2004058052A2 Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof
07/15/2004WO2004058042A2 Methods for evaluating genetic susceptibility and therapy for chronic inflammatory diseases
07/15/2004WO2004057940A2 Canine dioxin/aryl hydrocarbon receptor sequences
07/15/2004WO2004049274A3 2’-0-trisubstituted silyloxymethyl-ribonucleoside-derivative and method for preparing the same
07/15/2004WO2004043227A3 Polynucleotides for the amplification and detection of chlamydia trachomatis and neisseria gonorrhoeae
07/15/2004WO2004042363A3 In vivo imaging of e2f-regulated bioluminescent proteins
07/15/2004WO2004041076A3 Methods of detecting colorectal cancer
07/15/2004WO2004032599A3 Novel immunogenic proteins of leptospira
07/15/2004WO2004027081A3 Methods and composition for detecting targets
07/15/2004WO2004026260A3 Prophylactic and therapeutic hiv aptamers
07/15/2004WO2004024744A3 Production of glycosylated macrolides in e. coli
07/15/2004WO2004022713A3 Method for distinguishing ulcerative colitis from crohn's disease by detecting the presence of fecal anti-neutrophil cytoplasmic antibodies (anca)
07/15/2004WO2004007664A3 Nucleic acid vectors
07/15/2004WO2004005322A3 Humanized renilla reniformis green fluorescent protein as a scaffold
07/15/2004WO2003100022A3 Methods and dna constructs for high yield production of polypeptides
07/15/2004WO2003099209A3 Compositions and methods for screening and identifying anti-hcv agents
07/15/2004WO2003070965A9 The eaat2 promoter and uses thereof
07/15/2004US20040139500 Plastid division and related genes and proteins, and methods of use
07/15/2004US20040139497 Comprises expression vector coding insecticidal polypeptide for use in generation and propagation of insect resistant plants; boiological pest control
07/15/2004US20040139487 Transgenic animal and uses thereof
07/15/2004US20040138440 Aspergillus fumigatus cofilin
07/15/2004US20040138166 Viricides; prevent reproduction, infections
07/15/2004US20040138163 Anticancer agents; antiproliferative agents
07/15/2004US20040138117 administering proteins or polypeptides for prophylaxis or diagnosis of nervous system and gastrointerstinal disorders ; genetic engineering; drug screening
07/15/2004US20040137626 AAV ITR-mediated modulation
07/15/2004US20040137579 Protein complexes having factor VIII:C activity and production thereof
07/15/2004US20040137566 Identification of novel ms4a gene family members expressed by hematopoietic cells
07/15/2004US20040137561 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/15/2004US20040137522 Genes and proteins altering Tau-related neurodegeneration
07/15/2004US20040137502 for diagnosis, drug screening, clinical trial monitoring, the treatment of physiological disorders or infectious disease
07/15/2004US20040137486 correlates known sensory, physical, ingredient, or processing properties (color, taste, texture, pH, moisture content) with a spectrum of target species of microorganisms that are present
07/15/2004US20040137479 Compositions and methods for visual ribonuclease detection assays
07/15/2004US20040137474 by comparing gene patterns for breast cancer; for early diagnosis; kits
07/15/2004US20040137470 determining the sequence of alleles of a locus of interest, and quantitating a ratio for the alleles at said locus which indicates the presence or absence of a chromosomal abnormality; non-invasive method for fetal DNA testing
07/15/2004US20040137469 Peptide Nucleic Acids (PNA); an acid forming cleavable linker and a PNA dimer comprising an N-terminal base labile protecting group, cleavably linked to the solid support through the cleavable linker
07/15/2004US20040137468 Solid phase based nucleic acid assays combining high affinity and high specificity
07/15/2004US20040137453 Process for producing vinylated nucleic acid
07/15/2004US20040137449 Magnetic isolation and purification of nucleic acids
07/15/2004US20040137448 Isolated polypeptide of given sequence; expression vectors, host cells, antibodies, agonists, and antagonists; use in diagnosis and treatment of cell proliferative, neurological, developmental, and autoimmune/inflammatory disorders
07/15/2004US20040137441 Modulation of thyroid hormone receptor interactor 3 expression
07/15/2004US20040137011 Methods and compositions for the identification of antibiotics that are not susceptible to antibiotic resistance
07/15/2004US20040137010 gp120 and a nucleic acid aptamer that binds to gp120 and induces gp120 to undergo a conformational shift whereby an epitope to a membrane bound receptor is exposed that is capable of eliciting a humoral immune response
07/15/2004US20040136999 Melanoma antigens and methods of use
07/15/2004US20040136995 antibody, or fragment thereof, that specifically binds an ACT-4-h-1 receptor; has different binding specificity than a monoclonal antibody generated by hybridoma HBL106
07/15/2004US20040136948 Branched immunomodulatory compounds and methods of using the same
07/15/2004CA2756797A1 Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection
07/15/2004CA2511652A1 Enzymes and polynucleotides encoding the same
07/15/2004CA2511620A1 Nucleotide derivatives and dna microarray
07/15/2004CA2511503A1 Method and device for optimizing a nucleotide sequence for the purpose of expression of a protein
07/15/2004CA2511475A1 Immunostimulatory sequence oligonucleotides and methods of using the same
07/15/2004CA2511012A1 Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof
07/15/2004CA2510895A1 Genetic polymorphisms associated with stenosis, methods of detection and uses thereof
07/15/2004CA2510891A1 Rapid direct sequence analysis of multi-exon genes
07/15/2004CA2510645A1 Releasable polymer arrays
07/15/2004CA2510587A1 Nucleic acid amplification
07/15/2004CA2510362A1 Methods for evaluating genetic susceptibility and therapy for chronic inflammatory diseases
07/15/2004CA2509999A1 Btl-ii nucleic acids, proteins, and antibodies
07/15/2004CA2508985A1 Branched immunomodulatory compounds and methods of using the same
07/15/2004CA2508948A1 Human chondroitinase glycoprotein (chasegp), process for preparing the same, and pharmaceutical compositions comprising thereof
07/15/2004CA2508610A1 Assay for rnase h activity
07/15/2004CA2508228A1 Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection
07/14/2004EP1437408A1 Novel antisense oligonucleotide derivatives against hepatitis c virus
07/14/2004EP1437368A1 Composition for polymerising immobilisation of biological molecules and method for producing said composition
07/14/2004EP1436614A1 Methods of detection of conformational change in a nucleic acid duplex by treatment with oxidising or reactive agent as a result of exposure to environmental or chemical conditions
07/14/2004EP1436418A2 Transductin-1 and transductin-2 and applications to hereditary deafness
07/14/2004EP1436404A2 Engineered templates and their use in single primer amplification
07/14/2004EP1436384A2 Mutated abl kinase domains
07/14/2004EP1436328A2 G-protein coupled receptor
07/14/2004EP1436308A2 Antisense modulation of il-1 receptor-associated kinase-4 expression
07/14/2004EP1436014A1 Cationic lipids suitable for gene transfer
07/14/2004EP1436002A1 Use of peptide vectors to improve the immune response to antigens
07/14/2004EP1363935A4 Ter sites and ter binding proteins
07/14/2004EP1337541A4 Massive parallel method for decoding dna and rna
07/14/2004EP0986571B1 Novel sulfur transfer reagents for oligonucleotide synthesis
07/14/2004EP0754227B1 Chimeric complement inhibitor proteins
07/14/2004EP0749442B1 ISOLATED p27 PROTEIN AND ITS ENCODING NUCLEIC ACID MOLECULES
07/14/2004EP0604409B1 Oligonucleotide analogs for detecting and modulating rna activity and gene expression
07/14/2004CN1512998A Proteins producing altered immunogenic response and methods of making and using the same
07/14/2004CN1511847A Ubiquitin-like molecule coming from human dendritic cell and its codnig sequence and use
07/14/2004CN1511842A Rockfish insulin-like growth factor I gene and carrier containing said gene and recombined strain and its use
07/14/2004CN1511841A Homoeotic box gene 9Brn-1 from quail and its use
07/14/2004CN1157406C Novel, ATP-sensitive potassium-channel proteins and genes for the same
07/13/2004US6762298 Thermolabile phosphorus protecting groups, associated intermediates and methods of use
07/13/2004US6762290 Includes rna ligands that inhibit the interaction of a vegf receptor with vegf
07/13/2004US6762169 Improved transmembrane delivery of nucleosides conjugated to an arylpropionic acid ligand (ibuprofen) which has affinity for plasma protein albumin; antisense therapy
07/13/2004US6762052 The enzymes are useful in metabolism studies, in screening of compounds for biological or pharmacological activity, as well as serving as a bio-indicator of disease states or susceptibility to disease states
07/13/2004US6762048 System and apparatus for nucleic acid sequencing of single molecules by polymerase synthesis